In a video interview with CURE, Dr. Elizabeth K. Lee explained that how a treatment affects daily life matters as much as how well it works.
|Articles|October 15, 2014
How Will Breast Cancer Surgery and Treatment Improve Over the Next Five Years?
Patrick Borgen, MD, talks about advances in breast cancer surgery, faster clinical trials, and better genomic profiling.
Advertisement
Patrick Borgen, MD, talks about advances in breast cancer surgery, reconstruction, faster clinical trials, and better genomic profiling.
Advertisement
Related to this article
Dr. Neel Chudgar of Montefiore Einstein answers the most searched questions about lung cancer surgery, including risks, recovery and recurrence.
Rinatabart sesutecan shrank tumors in 45.9% of patients with platinum-resistant ovarian cancer in a phase 2 study, with responses lasting a median of 12.1 months.
A leukemia survivor recalls how bonding with other patients helped his hospital stays go by faster and became a key part of his emotional healing.
Advertisement
Advertisement
Trending on CURE
1
Why PSA Monitoring Matters After a Prostate Cancer Diagnosis
2
Rectal Cancer Tumor DNA Fell From 45.8% to 8.7% After Chemotherapy
3
ESMO 2026 Preview: 5 Late-Breaking Trials Patients Should Watch
4
FDA Withdraws Zepzelca Approval for Previously Treated Small Cell Lung Cancer
5